Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy
C Xu, S Li, J Chen, H Wang, Z Li, Q Deng, J Li… - Journal of Controlled …, 2023 - Elsevier
Cancer stem cells (CSCs), enabled to self-renew, differentiate, and initiate the bulk tumor,
are recognized as the culprit of treatment resistance, metastasis, and recurrence …
are recognized as the culprit of treatment resistance, metastasis, and recurrence …
Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles
Doxorubicin (DOX) has been extensively used to treat a wide range of cancers in free and
nanotized form. Nanotization of DOX has alleviated its toxicity and efflux-mediated …
nanotized form. Nanotization of DOX has alleviated its toxicity and efflux-mediated …
Breaking the intracellular redox balance with diselenium nanoparticles for maximizing chemotherapy efficacy on patient-derived xenograft models
Excessive oxidative stress in cancer cells can induce cancer cell death. Anticancer activity
and drug resistance of chemotherapy are closely related to the redox state of tumor cells …
and drug resistance of chemotherapy are closely related to the redox state of tumor cells …
pH and redox dual-responsive nanoparticles based on disulfide-containing poly (β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug …
S Zhang, N Guo, G Wan, T Zhang, C Li, Y Wang… - Journal of …, 2019 - Springer
Background Multidrug resistance (MDR) generally leads to breast cancer treatment failure.
The most common mechanism of MDR is the overexpression of ATP-binding cassette (ABC) …
The most common mechanism of MDR is the overexpression of ATP-binding cassette (ABC) …
Redox‐responsive dual drug delivery nanosystem suppresses cancer repopulation by abrogating doxorubicin‐promoted cancer stemness, metastasis, and drug …
J Liu, B Chang, Q Li, L Xu, X Liu, G Wang… - Advanced …, 2019 - Wiley Online Library
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …
pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells
U Luesakul, S Puthong, N Neamati, N Muangsin - Carbohydrate polymers, 2018 - Elsevier
Herein, we first report pH-responsive SeNPs stabilized with modified folic acid-N-trimethyl
chitosan (TMC-FA) as nanocarriers for delivery of doxorubicin (DOX) to overcome drug …
chitosan (TMC-FA) as nanocarriers for delivery of doxorubicin (DOX) to overcome drug …
Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance
Y Xiao, J Liu, M Guo, H Zhou, J Jin, J Liu, Y Liu… - Nanoscale, 2018 - pubs.rsc.org
A key challenge of chemotherapy in clinical treatments is multidrug resistance (MDR), which
mainly arises from drug efflux-induced tumor cell survival. Thus, it is necessary to provide …
mainly arises from drug efflux-induced tumor cell survival. Thus, it is necessary to provide …
Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
Y Zhao, M Huan, M Liu, Y Cheng, Y Sun, H Cui, D Liu… - Scientific reports, 2016 - nature.com
With the extensive application of doxorubicin (DOX), DOX resistance has become one of the
main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol …
main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol …
A novel ROS-activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone
H Zhang, W Chen, J Wang, W Du, B Wang, L Song… - Biomaterials, 2023 - Elsevier
Reactive oxygen species (ROS) as well-known endogenous stimuli has been widely used to
activate drug delivery systems (DDSs) for tumor-specific therapy. Unfortunately, endogenous …
activate drug delivery systems (DDSs) for tumor-specific therapy. Unfortunately, endogenous …
[HTML][HTML] Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer
X Zhang, Y Yang, X Liang, X Zeng, Z Liu, W Tao… - Theranostics, 2014 - ncbi.nlm.nih.gov
Dendrimers are synthetic nanocarriers that comprise a highly branched spherical polymer
as new, efficient tools for drug delivery. However, the fate of nanocarriers after being …
as new, efficient tools for drug delivery. However, the fate of nanocarriers after being …